Literature DB >> 1814568

Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance.

R J Carey1.   

Abstract

Two separate experiments were conducted to assess the behavioral and biochemical effects of chronic L-dihydroxyphenylalanine (L-DOPA) treatment in rats with unilateral 6-hydroxydopamine (6-OHDA) lesions. In this animal model, contralateral rotation provides the behavioral indicator response for L-DOPA activation of the dopamine denervated striatum. Following 30 daily L-DOPA treatments, a subthreshold dose (10 mg/kg) for rotation became suprathreshold and the contralateral rotation induced by a suprathreshold dose (20 mg/kg) became exaggerated. This motoric sensitization to L-DOPA was not reversed by a three-day period of L-DOPA withdrawal. In contrast with the emergence of behavioral sensitization to L-DOPA, biochemical measurements showed that the increase of dopamine metabolite concentrations (DOPAC and HVA) induced by acute L-DOPA treatment became attenuated with chronic treatment. This finding suggests that chronic L-DOPA treatment produces a partial tolerance in the conversion of L-DOPA to extracellular dopamine. The emergence of L-DOPA sensitization-over-stimulation effects was hypothesized to reflect the combined effects of dopamine receptor priming and Pavlovian drug conditioning and to contribute to the emergence of dyskinetic effects of L-DOPA therapy. The partial tolerance observed for dopamine metabolites was hypothesized to represent a decreased conversion of L-DOPA to dopamine which with long-term treatment could progress to an eventual wearing-off effect of L-DOPA therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1814568     DOI: 10.1016/0006-8993(91)91399-l

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Authors:  Manfred Gerlach; Jürgen Beck; Peter Riederer; Maarten van den Buuse
Journal:  J Neural Transm (Vienna)       Date:  2011-01-28       Impact factor: 3.575

Review 2.  Pharmacological study of the novel compound FLZ against experimental Parkinson's models and its active mechanism.

Authors:  Weihong Feng; Huailing Wei; Geng Tao Liu
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

3.  Restoration and putative protection in Parkinsonism.

Authors:  T Archer; A Fredriksson
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

4.  The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat.

Authors:  John E Kelsey; Nicole A Langelier; Brad S Oriel; Catherine Reedy
Journal:  Psychopharmacology (Berl)       Date:  2008-09-13       Impact factor: 4.530

5.  Residual dopamine receptor desensitization following either high- or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine.

Authors:  Flávia Regina Cruz Dias; Liana Wermelinger de Matos; Maria de Fátima Dos Santos Sampaio; Robert J Carey; Marinete Pinheiro Carrera
Journal:  Psychopharmacology (Berl)       Date:  2012-07-24       Impact factor: 4.530

6.  Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors.

Authors:  Silva Fredduzzi; Rosario Moratalla; Angela Monopoli; Beatriz Cuellar; Kui Xu; Ennio Ongini; Francesco Impagnatiello; Michael A Schwarzschild; Jiang-Fan Chen
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

7.  Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Authors:  Manfred Gerlach; Gerd D Bartoszyk; Peter Riederer; Olivia Dean; Maarten van den Buuse
Journal:  J Neural Transm (Vienna)       Date:  2011-01-21       Impact factor: 3.575

8.  Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion.

Authors:  N Yamamoto; J-J Soghomonian
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

9.  The dopamine D3 receptor and drug addiction.

Authors:  P Sokoloff; B Le Foll; S Perachon; R Bordet; S Ridray; J C Schwartz
Journal:  Neurotox Res       Date:  2001-10       Impact factor: 3.911

10.  Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2.

Authors:  M G Morgese; T Cassano; S Gaetani; T Macheda; L Laconca; P Dipasquale; L Ferraro; T Antonelli; V Cuomo; A Giuffrida
Journal:  Neurochem Int       Date:  2008-11-01       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.